Recent

% | $
Quotes you view appear here for quick access.

Geron Corporation Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • formerblueguy formerblueguy Dec 9, 2006 3:47 PM Flag

    Dr. Okarma to tell more about progress at ASH conference Dec. 9-12th

    Here are the abstracts/info I pulled from the conference program.

    Regards,
    FBG

    . [2595] GRN163L, a Potent and Specific Inhibitor of Telomerase: Integrated Pharmacokinetic, Pharmacodynamic, and Safety Data Guides Design of Practical Treatment Regimens for Targeting Inhibitory Levels in Patients. Session Type: Poster Session, Board #773-II
    Authors: Robert J. Tressler, Allison C. Chin, Eric J. Feldman, Kanti R. Rai, Doug Kornbrust, Calvin B. Harley, Melissa A. Kelly Behrs, Laurence Elias
    Date/Time: Sunday, December 10, 2006 - 9:00 AM
    Session Info: Poster Session: Molecular Pharmacology, Drug Resistance II (9:00 AM-8:00 PM)



    4. [2540] Cancer Stem Cell Targeting in Multiple Myeloma by GRN163L, a Novel and Potent Telomerase Inhibitor. Session Type: Poster Session, Board #718-II
    Authors: William Matsui, Qiuju Wang, Milada Vala, James P. Barber, Alan Meeker, Robert Tressler, Calvin Harley, Carol A. Huff, B. Douglas Smith, Richard J. Jones
    Date/Time: Sunday, December 10, 2006 - 9:00 AM
    Session Info: Poster Session: Malignant Stem and Progenitor Cells (9:00 AM-8:00 PM)

 
GERN
2.79-0.05(-1.76%)10:18 AMEDT